Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) is -22.14% lower on its value in year-to-date trading and has touched a low of $12.51 and a high of $22.80 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The TEVA stock was last observed hovering at around $16.57 in the last trading session, with the day’s gains setting it 0.59%.
Currently trading at $17.16, the stock is -5.97% and -12.33% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 16.29 million and changing 3.56% at the moment leaves the stock -3.70% off its SMA200. TEVA registered 30.00% gain for a year compared to 6-month gain of -6.02%.
The stock witnessed a -21.72% loss in the last 1 month and extending the period to 3 months gives it a 2.45%, and is 3.44% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.69% over the week and 3.44% over the month.
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) has around 36167 employees, a market worth around $19.46B and $16.53B in sales. Fwd P/E is 6.06. Profit margin for the company is -9.91%. Distance from 52-week low is 37.17% and -24.74% from its 52-week high. The company has generated returns on investments over the last 12 months (-7.56%).
with sales reaching $4B over the same period.The EPS is expected to grow by 4.45% this year, but quarterly earnings will post 3.16% year-over-year. Quarterly sales are estimated to grow 4.68% in year-over-year returns.
The shares outstanding are 1.13B, and float is at 1.13B with Short Float at 1.97%.
The top institutional shareholder in the company is BLACKROCK INC. with over 42.99 million shares valued at $698.55 million. The investor’s holdings represent 3.8279 of the TEVA Shares outstanding. As of 2024-06-30, the second largest holder is FMR LLC with 41.98 million shares valued at $682.15 million to account for 3.7381 of the shares outstanding. The other top investors are ION ASSET MANAGEMENT LTD. which holds 36.33 million shares representing 3.2351 and valued at over $590.36 million, while CLAL INSURANCE ENTERPRISES HOLDINGS LTD holds 2.8797 of the shares totaling 32.34 million with a market value of $525.67 million.
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Insider Activity
The most recent transaction is an insider sale by Francis Richard D, the company’s President and CEO. SEC filings show that Francis Richard D sold 75,506 shares of the company’s common stock on Feb 18 ’25 at a price of $16.95 per share for a total of $1.28 million. Following the sale, the insider now owns 0.21 million shares.
Still, SEC filings show that on Feb 12 ’25, Sabag Mark (See “Remarks”) disposed off 177,626 shares at an average price of $16.25 for $2.89 million. The insider now directly holds 204,964 shares of Teva- Pharmaceutical Industries Ltd. ADR (TEVA).
